Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zentalis Pharmaceuticals Inc
(NQ:
ZNTL
)
3.190
+0.110 (+3.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zentalis Pharmaceuticals Inc
< Previous
1
2
3
Next >
Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL
August 19, 2024
From
Newman Ferrara LLP
Via
Business Wire
Zentalis Pharmaceuticals, Inc. (ZNTL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 13, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024
August 09, 2024
ZNTL stock results show that Zentalis Pharma missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
ZNTL Investors Have Opportunity to Join Zentalis Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
August 01, 2024
From
The Schall Law Firm
Via
Business Wire
(ZNTL) - Analyzing Zentalis Pharma's Short Interest
June 21, 2024
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, June 22
June 22, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of June 17-21, 2024.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
June 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 19, 2024
Via
Benzinga
Analyst Expectations for Zentalis Pharma's Future
November 07, 2023
Via
Benzinga
Where Zentalis Pharma Stands With Analysts
August 10, 2023
Via
Benzinga
Analyst Expectations for Zentalis Pharma's Future
June 07, 2023
Via
Benzinga
Zentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b Outcomes
May 26, 2023
Via
Benzinga
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 18, 2024
Via
Benzinga
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
June 18, 2024
Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths.
Via
Benzinga
Exposures
Product Safety
Where Zentalis Pharma Stands With Analysts
May 19, 2023
Via
Benzinga
Zentalis Pharma: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 18, 2024
Via
Benzinga
ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
ZNTL stock results show that Zentalis Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 28, 2024
Via
Benzinga
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
February 22, 2024
MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.
Via
Talk Markets
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
January 08, 2024
From
Immunome, Inc.
Via
Business Wire
Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know
November 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 06, 2023
Via
Benzinga
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
November 06, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Around $108M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
June 21, 2023
Although US stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More
June 15, 2023
Via
Benzinga
Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday
June 15, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to...
Via
Benzinga
Why Shares of Zentalis Pharmaceuticals Dropped This Week
June 02, 2023
A rash of insider selling meant the stock gave back some of its gains from last week.
Via
The Motley Fool
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.